bpc-157 human clinical trials safety adverse events The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and The Stable Gastric Pentadecapeptide BPC

Petersen RC, Lopez O, Armstrong MJ, et al

Now, Im not always about bashing the NHS, in fact Im one of the biggest supporters and always try to work constructively with doctors whether in primary or secondary care

10.1016/j.carbpol.2020.117108 164 RavindranS.SutharJ

What makes AOD-9604 unique is its selective action on fat metabolism without producing the other effects associated with full-length human growth hormone, such as increased blood glucose levels, insulin resistance, or excessive IGF-1 production

Oral administration is the most logical route for gut-focused applications, since the peptide is uniquely stable in gastric juice